1025203

Aerie Pharmaceuticals, Inc. — FEI 3013612600

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 23, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Bedminster, NJ (United States)

Additional Details

Sponsor, Contract Research Organization